Zoetis Inc. financial data

Symbol
ZTS on NYSE
Industry
Pharmaceutical Preparations
Location
10 Sylvan Way, Parsippany, New Jersey
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 350 % +42.9%
Quick Ratio 149 % +73.8%
Debt-to-equity 186 % -11.2%
Return On Equity 48.5 % +6.09%
Return On Assets 16.9 % +14.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 456 M shares -1.26%
Common Stock, Shares, Outstanding 457 M shares -1.2%
Entity Public Float 79.3 B USD -1.5%
Common Stock, Value, Issued 5 M USD 0%
Weighted Average Number of Shares Outstanding, Basic 458 M shares -1.19%
Weighted Average Number of Shares Outstanding, Diluted 459 M shares -1.25%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 8.73 B USD +7.91%
Nonoperating Income (Expense) 114 M USD +470%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2.99 B USD +13.7%
Income Tax Expense (Benefit) 598 M USD +7.17%
Net Income (Loss) Attributable to Parent 2.39 B USD +15.5%
Earnings Per Share, Basic 5.2 USD/shares +17.1%
Earnings Per Share, Diluted 5.19 USD/shares +17.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.98 B USD -6.35%
Accounts Receivable, after Allowance for Credit Loss, Current 1.29 B USD +9.02%
Inventory, Net 2.65 B USD +3.43%
Other Assets, Current 440 M USD +7.06%
Assets, Current 6.36 B USD +1.44%
Deferred Income Tax Assets, Net 232 M USD +44.1%
Property, Plant and Equipment, Net 3.25 B USD +11.6%
Operating Lease, Right-of-Use Asset 225 M USD +4.17%
Intangible Assets, Net (Excluding Goodwill) 1.3 B USD -1.45%
Goodwill 2.76 B USD +0.77%
Other Assets, Noncurrent 227 M USD +58.7%
Assets 14.3 B USD +4.32%
Accounts Payable, Current 405 M USD -4.48%
Employee-related Liabilities, Current 272 M USD +17.2%
Accrued Liabilities, Current 683 M USD +0.15%
Liabilities, Current 1.91 B USD -0.31%
Accrued Income Taxes, Noncurrent 277 M USD +5.73%
Deferred Income Tax Liabilities, Net 136 M USD +3.82%
Operating Lease, Liability, Noncurrent 184 M USD +2.22%
Other Liabilities, Noncurrent 228 M USD +5.56%
Liabilities 9.3 B USD +0.36%
Accumulated Other Comprehensive Income (Loss), Net of Tax -841 M USD -1.57%
Retained Earnings (Accumulated Deficit) 10.7 B USD +18.3%
Stockholders' Equity Attributable to Parent 5.06 B USD +12.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.05 B USD +12.5%
Liabilities and Equity 14.3 B USD +4.32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 595 M USD +8.38%
Net Cash Provided by (Used in) Financing Activities -524 M USD +70.9%
Net Cash Provided by (Used in) Investing Activities -131 M USD +39.4%
Common Stock, Shares Authorized 6 B shares 0%
Common Stock, Shares, Issued 502 M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -66 M USD +95.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.98 B USD -6.35%
Interest Paid, Excluding Capitalized Interest, Operating Activities 68 M USD -23.6%
Deferred Tax Assets, Valuation Allowance 131 M USD +1.55%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 236 M USD +3.06%
Depreciation 306 M USD +12.5%
Payments to Acquire Property, Plant, and Equipment 140 M USD -37.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2.38 B USD +22.1%
Lessee, Operating Lease, Liability, to be Paid 271 M USD -3.21%
Property, Plant and Equipment, Gross 5.8 B USD +14.8%
Operating Lease, Liability, Current 48 M USD +11.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 48 M USD +6.67%
Lessee, Operating Lease, Liability, to be Paid, Year One 57 M USD +9.62%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure +36%
Deferred Income Tax Expense (Benefit) -43 M USD -638%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 35 M USD -31.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 38 M USD +2.7%
Deferred Tax Assets, Operating Loss Carryforwards 133 M USD +18.8%
Preferred Stock, Shares Authorized 1 B shares 0%
Unrecognized Tax Benefits 212 M USD +8.16%
Lessee, Operating Lease, Liability, to be Paid, Year Four 30 M USD -3.23%
Operating Lease, Payments 15 M USD +7.14%
Additional Paid in Capital 1.13 B USD +4.36%
Amortization of Intangible Assets 182 M USD -3.19%
Depreciation, Depletion and Amortization 497 M USD +5.52%
Deferred Tax Assets, Net of Valuation Allowance 232 M USD +44.1%
Share-based Payment Arrangement, Expense 18 M USD +100%
Interest Expense 234 M USD +1.3%